ANESTHISA
ActiveANESTHISA has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €210k and a net result of €140k. Equity is growing by ~21.1% per year across the filed fiscal years. Its solvency ranks better than 44% of 16414 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
98
/ 100
Excellent▼ -2 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency97▼-2
Growth78=
Stability100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €21k at 30 days acceptable
Liquidity ample (current ratio 2.84 against 4.37 in 2024), and 44.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
55.7%
Return on assets
37.1%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
21 d late
2023
23 d early
2022
39 d early
2021
29 d late
2020
13 d late
2019
2 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€210k▼ 6.9%
2024 · €226k
2018: €77k
2019: €77k
2020: €69k
2021: €144k
2022: €69k
2023: €118k
2024: €226k
2018 → 2025
Total assets
€378k▲ 3.1%
2024 · €366k
2018: €446k
2019: €403k
2020: €285k
2021: €298k
2022: €290k
2023: €284k
2024: €366k
2018 → 2025
Net result
€140k▲ 23.2%
2024 · €114k
2018: €81k
2019: €60k
2020: €35k
2021: €75k
2022: €93k
2023: €99k
2024: €114k
2018 → 2025
Working capital
€216k▼ 10.4%
2024 · €241k
2018: €186k
2019: €199k
2020: €100k
2021: €170k
2022: €92k
2023: €140k
2024: €241k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€144k-€69k▼ 52.2%€118k▲ 71.4%€226k▲ 91.1%€210k▼ 6.9%
Operating result€101k-€123k▲ 21.4%€129k▲ 5.4%€156k▲ 20.8%€201k▲ 28.6%
Net result€75k-€93k▲ 24.9%€99k▲ 6.2%€114k▲ 14.7%€140k▲ 23.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 29% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €378k
Fixed assets
€45k▼ 17.4%
Current assets
€333k▲ 6.7%
Equity and liabilities €378k
Equity
€210k▼ 6.9%
Debt
€167k▲ 19.2%
The debt ratio rises from 38.3% to 44.3%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€215k▲
2024 · €171k
Cash flow
€155k▲
2024 · €129k
Solvency
55.7%▼
2024 · 61.7%
Current ratio
2.84▼
2024 · 4.37
Quick ratio
2.84▼
2024 · 4.37
Debt / equity
0.80▲
2024 · 0.62
ROE
66.7%▲
2024 · 50.4%
ROA
37.1%▲
2024 · 31.1%
Interest coverage
62.89▲
2024 · 38.80
Debt
€167k▲
2024 · €140k
Debt ≤ 1 year
€117k▲
2024 · €71k
Debt > 1 year
€50k▼
2024 · €69k
Income taxes
€61k▲
2024 · €41k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€366k€378k▲
Fixed assets21/28€54k€45k▼
Tangible fixed assets22/27€54k€45k▼
Land and buildings22€53k€39k▼
Furniture and vehicles24€2k€6k▲
Current assets29/58€312k€333k▲
Amounts receivable within one year40/41€38k€65k▲
Trade receivables40-€2k
Other amounts receivable41€38k€64k▲
Current investments50/53€70k€70k=
Cash at bank and in hand54/58€196k€191k▼
Deferred charges and accrued income490/1€9k€6k▼
Equity and liabilities
Total equity and liabilities10/49€366k€378k▲
Equity10/15€226k€210k▼
Reserves13€97k€202k▲
Distributable reserves133€97k€202k▲
Profit (loss) carried forward14€129k€9k▼
Amounts payable17/49€140k€167k▲
Amounts payable after more than one year17€69k€50k▼
Financial debts170/4€69k€50k▼
Amounts payable within one year42/48€71k€117k▲
Current portion of amounts payable after more than one year42€20k€20k▼
Trade debts44€45k€381▼
Suppliers440/4€45k€381▼
Taxes, remuneration and social security45€6k€26k▲
Taxes450/3€6k€26k▲
Other amounts payable47/48-€70k
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15k€14k▼
Other operating charges640/8€3k€3k▲
Gross operating margin9900€173k€218k▲
Operating profit (loss)9901€156k€201k▲
Financial income75/76B€3k€4k▲
Recurring financial income75€3k€4k▲
Financial charges65/66B€4k€3k▼
Recurring financial charges65€4k€3k▼
Profit (loss) for the period before taxes9903€155k€201k▲
Income taxes67/77€41k€61k▲
Profit (loss) for the period9904€114k€140k▲
Profit (loss) for the period to be appropriated9905€114k€140k▲
Appropriation of the result
Profit (loss) to be appropriated9906€189k€269k▲
Profit (loss) brought forward from the previous period14P€75k€129k▲
Transfer from equity791/2-€35k
Transfer to equity691/2€60k€140k▲
To other reserves6921€60k€140k▲
Profit to be distributed694/7-€156k
Return on contributions (dividend)694-€156k
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
31-12
Financial
Highest result since 2018net €140k ▲23.2%
Operating result €201k, net result €140k, both a record.
21-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 21 days late
2024
31-12
Financial
Equity above €200kEq €226k ▲91.1%
7 profitable years in a row build equity to €226k.
08-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €100kEq €118k ▲71.4%
6 profitable years in a row build equity to €118k.
22-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 29 days late
2021
31-12
Financial
Liquidity triplescurrent ratio 7.03
Current ratio from 2.40 to 7.03; short-term debt falls from €71k to €28k.
31-12
Financial
Equity above €100kEq €144k ▲108%
4 profitable years in a row build equity to €144k.
13-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 13 days late
2020
31-12
Financial
Weakest financial yearnet €35k ▼41.2%
Net result drops to €35k, the lowest in the series; recovery starts the following year.
29-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
09-09
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 40 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 30 days late
2017
11-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Jette
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Jetse Laan 1671090 JetteGround area
195 m²
Building footprint
100 m²
Volume, LiDAR
1,096 m³
Parcel 21464E0036/00H013, Brussels · tallest building 17.2 m, ±3 floors. Linked by address, not a title deed.
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21464E0036/00H013 | Brussels | 195 m² | 1 · 100 m² | 17.2 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
699400K2IIBBD6YGKP41
Similar companies · same sector, comparable size
Dr. Gabriele Giunta
BE 0788.957.319
Ukkel · Eq €210k
Dr. B. Vandendriessche Endocrino
BE 0779.975.515
Merelbeke-Melle · Eq €210k
MEDISKIN
BE 0655.933.992
Dilbeek · Eq €210k
Dr. Ghislaine Peene
BE 0734.532.104
Kortrijk · Eq €211k
DR MIGLIONICO
BE 1008.690.528
Ganshoren · Eq €211k
Of 16,604 companies in sector 86220 we hold annual accounts for 7,961. 6,643 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-07-2001
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 24 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:anesthisa_andrianne@yahoo.fr